Latest News

Oct 10, 2020 - News & Press

COVID 19 Test system successfully refined

CeNTech initiated a transnational collaboration that lead to a successful refinement of a COVID 19 test System. The British company Eluceda,, is currently undergoing clinical validation of a new PCR free rapid test system for the virus SARS-CoV-2. As the company was unable to obtain suitable corona samples within the UK during lockdown, the EU project MATMED introduced and funded a collaboration with the German diagnostic company Carpegen GmbH, The company from Münster provided corona samples and furthermore analyzed the sample using two different standard PCR procedures - Carpegen´s in-house SARS-CoV-2 assay and a commercial SARS-CoV-2 detection kit. The collaboration led to a significant acceleration of the technology readiness level of the corona test technology. For additional information about the MATMED voucher funding system click on

Read on

September 30, 2020 - News & Press

Johannes Striebel awarded for his master thesis

Johannes Striebel received the "Best Thesis Awards 2020 Masterarbeit" by the Institut für Bioprozess- und Analysenmesstechnik e.V. (iba) for his master thesis "Harnessing Macrophages for Cancer Immunotherapy - Adhesion Arrays for Selective Macrophage Capture and Differentiation via Surface Structures" supervised by Dr. Kristina Riehemann, Cell Culture/Nanomedicine Division at CeNTech. The prize was endowed with 1250 Euro.

Read on

Jun 16, 2020 - News & Press

Successful MATMED training workshop on new EU MDR regulation

The first MATMED training workshop on the new MDR regulation took place at CeNTech and got a very positive feedback from the participants. Christian Rosenzweig (Johner Institut GmbH, Konstanz) explained and discussed the EU regulation on medical devices and in-vitro diagnostics with the participants. The attending SMEs expressed their needs for additional workshops and a platform for knowledge exchange.

Read on